The expression levels of FOXM1, PHB1, ABCA2 and p-ERK1/2 were up-regulated in PC cells and paclitaxel-resistant cell lines, and were also proportional to the drug dose 273. The gene discussed is MAPK3; the disease is pachyonychia congenita.